Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study

29 Pages Posted: 13 Oct 2003 Last revised: 22 May 2022

See all articles by Richard G. Frank

Richard G. Frank

Harvard Medical School; National Bureau of Economic Research (NBER)

Ernst R. Berndt

Massachusetts Institute of Technology (MIT) - Sloan School of Management; National Bureau of Economic Research (NBER)

Alisa Busch

McLean Hospital

Anthony F. Lehman

University of Maryland, Baltimore County (UMBC) - Department of Psychiatry

Date Written: October 2003

Abstract

Health care expenditures have been increasing sharply in the last ten years, with spending on mental health disorders being particularly prominent. Over the same time period, a number of new antipsychotic medications have been added to the armamentarium for treatment of persons diagnosed with schizophrenia. Due in part to the sharply increased expenditures by Medicaid on mental health disorders such as schizophrenia, controversies have arisen as to the use of these more costly innovative medications, particularly their impact on the annualized cost of treating patients. Using Medicaid data on 12,864 person years from two counties in Florida over the 1994-95 to 1999-2000 time period, in this study we address three issues: (i) On a per person year basis, what is happening over time to the mental health-related costs of treating schizophrenia? (ii) How is the composition and quality of care changing over time? and (iii) Holding quality of care constant, on a per person year basis, by how much are the costs for the ongoing treatment of schizophrenia changing? We find that unadjusted for changes in quality of care over time, the annualized costs for the ongoing treatment of schizophrenia per person have increased about 0.5% per year. The composition of treatments for schizophrenia has changed substantially over this six-year time period, toward more intensive use of atypical antipsychotics, and away from psychotherapy. Holding treatment quality type and patient characteristics constant over time, mean treatment costs have fallen about 5.5% per year between 1994-1995 and 1999-2000.

Suggested Citation

Frank, Richard G. and Berndt, Ernst R. and Busch, Alisa and Lehman, Anthony F., Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study (October 2003). NBER Working Paper No. w10022, Available at SSRN: https://ssrn.com/abstract=457544

Richard G. Frank (Contact Author)

Harvard Medical School ( email )

Department of Health Care Policy
Boston, MA 02115
United States
617-432-0178 (Phone)
617-432-1219 (Fax)

National Bureau of Economic Research (NBER)

1050 Massachusetts Avenue
Cambridge, MA 02138
United States

Ernst R. Berndt

Massachusetts Institute of Technology (MIT) - Sloan School of Management ( email )

Room E52-452
Cambridge, MA 02142
United States
617-253-2665 (Phone)
617-258-6055 (Fax)

National Bureau of Economic Research (NBER)

1050 Massachusetts Avenue
Cambridge, MA 02138
United States

Alisa Busch

McLean Hospital ( email )

115 Mill Street
Proctor Building
Belmont, MA 02478
United States

Anthony F. Lehman

University of Maryland, Baltimore County (UMBC) - Department of Psychiatry ( email )

701 West Pratt Street
Suite 388
Baltimore, MD 21201-1549
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
52
Abstract Views
1,721
Rank
707,582
PlumX Metrics